Skip to main content
. Author manuscript; available in PMC: 2014 Mar 14.
Published in final edited form as: Mol Pharmacol. 2001 Nov;60(5):1057–1063.

Fig. 1.

Fig. 1

Chemical structures of the compounds tested in this study. A, isoquinoline derivatives found to enhance A3 agonist binding. B, isoquinoline derivatives that did not enhance A3 agonist binding. C, A1 allosteric enhancer.